Last reviewed · How we verify
NCT05137691: HABIT
Health After Birth Intervention Trial
NA trial testing Adapted NHS weight management 1:1 programme in Obesity in 3 participants. Terminated before completion.
15 September 2022
Quick facts
| Lead sponsor | Queen Margaret University |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 3 |
| Start date | 19 May 2022 |
| Primary completion | 15 September 2022 |
| Estimated completion | 15 September 2022 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Adapted NHS weight management 1:1 programme
- NHS 1:1 weight management programme
Conditions studied
- Obesity — all drugs for Obesity →
Sponsor
Queen Margaret University
Who can join
18 and older, female only, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial is to assess the feasibility of a larger, definitive RCT and determine the clinical effectiveness of an NHS 1:1 programme versus a modified programme with a low carbohydrate dietary intervention (as per Feinman and colleagues classification) with telehealth, physical activity and enhanced behaviour change on specified health outcomes amongst post-partum women living with obesity
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05137691
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Queen Margaret University trials
Trials by the same sponsor.
- NCT06911151 — Innovative Shoe for People With Foot Drop · NA · not yet recruiting
- NCT06046846 — Prehabilitation Via a Mobile Application in Oesophago-gastric Cancer · NA · unknown
- NCT05453656 — Development and Testing of the Kidney BEAM-KIDS Digital Platform for Children After Kidney Transplantation · NA · unknown
- NCT05234879 — The Feasibility of Frame Running as an Exercise Option for People With Multiple Sclerosis · NA · completed
- NCT05252104 — Inter-rater Reliability of Diagnosing Thoracic Outlet Syndrome by Physiotherapists · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05137691 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Queen Margaret University
- Last refreshed: 21 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05137691.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing